Questions discussed in this category
Do the results of the recent study (Misset et al., PMID 37889107) showing reduction in 28-day mortality in patients with high neutralizing antibody ti...
How do you approach which risk to accept given that steroids have evidence for use in COVID-19 while is suggestion for harm in using steroids in influ...
Current guidelines do not support its use, but the EMPACTA trial suggests it may be effective in a subpopulation of patients.
Please see this article for referrence https://www.sciencedirect.com/science/article/pii/S0167814020301638
Should the patient be admitted for observation which will risk exposing other immunocompromised patients to COVID-19, or should the patient be quarant...
2167120157149848533896770036949689567786779
Papers discussed in this category
Lancet Oncol., 2020 Feb 14
Ann. Oncol., 2020 Mar 26
Hong Kong medical journal = Xianggang yi xue za zhi, 2003-12
Lancet, 2020 Mar 04
Intensive Care Med, 2020 Mar 03
Lancet, 2020 Jan 24
Int J Antimicrob Agents, 2020 Feb 17
Cell Res, 2020 Feb 04
Biosci Trends, 2020 Jan 28
Acta Paediatr., 2020 Mar 23
N Engl J Med, 2020 Dec 10
N Engl J Med, 2020 Dec 17